Aaron Keller is a seasoned professional in business insights and analytics, currently serving as the Senior Director for Oncology and Immunology at Eli Lilly and Company. Previously, Aaron held various roles, including Economic Research Analyst at the Federal Trade Commission, where they analyzed competitive effects of mergers, and Senior Business Analyst at Freedom Mortgage, focusing on capacity modeling. Aaron earned a Bachelor of Arts in Quantitative Economics from Providence College and a Master of Business Administration from Vanderbilt University's Owen Graduate School of Management. Early in their career, Aaron gained experience as an Acquisitions Analyst at Axiom Resource Management, Inc. and as an Economic Policy Intern at the U.S. Department of Commerce.
This person is not in the org chart
This person is not in any teams
This person is not in any offices